Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,248,186
+$533,675 QoQ
Shares Held
16,882
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#1,421
of 4,153 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WCG Wealth Advisors LLC holds $47,610,651 across 10 Drug Manufacturers - General names. ABBV ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,452 | $12,536,443 | |
| 2 | JNJ |
Johnson & Johnson
|
41,061 | $10,428,262 | |
| 3 | NVS |
Novartis AG
|
43,776 | $6,860,574 | |
| 4 | AMGN |
Amgen Inc
|
13,208 | $4,782,880 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
16,882 | $4,248,186 | |
| 6 | MRK |
Merck & Co., Inc.
|
23,852 | $3,064,982 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
43,889 | $2,528,884 | |
| 8 | PFE |
Pfizer Inc
|
79,512 | $1,914,648 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,248,186 | 16,882 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,714,511 | 17,079 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,904,208 | 17,087 | Shares | Sole | 2026-02-10 | |
| 2024-03-31 | $2,057,912 | 11,301 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,123,398 | 13,702 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,916,017 | 12,854 | Shares | Sole | 2023-11-13 | |
| 2022-09-30 | $187,625 | 1,398 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $30,063 | 224 | Principal | Sole | 2022-11-14 | |
| 2022-06-30 | $318,879 | 2,082 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||